OptimizeRx Corporation (OPRX) Operating cash flow 2016–2025
OptimizeRx Corporation (OPRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$18.7MFY2025 · since FY2016: -$465,965 → $18.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $18.7M | +282.8% |
| FY2024 | $4.9M | +167.5% |
| FY2023 | -$7.2M | -168.0% |
| FY2022 | $10.7M | +1367.4% |
| FY2021 | $726,039 | +111.5% |
| FY2020 | -$6.3M | -280.0% |
| FY2019 | -$1.7M | -309.5% |
| FY2018 | $792,555 | +153.6% |
| FY2017 | -$1.5M | -217.6% |
| FY2016 | -$465,965 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OPRX financial trends
OPRX RevenueOPRX Net incomeOPRX Net marginOPRX Gross profitOPRX Gross marginOPRX Operating incomeOPRX Operating marginOPRX Free cash flowOPRX Capital expendituresOPRX Return on equityOPRX Stock buybacksOPRX Dividends paidOPRX Total assetsOPRX Total liabilitiesOPRX Shareholders’ equityOPRX overview →